EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Bexagliflozin controls hyperinsulinemia in horses with naturally occurring insulin dysregulation: a placebo-controlled crossover trial

Caitrin R Lowndes, Daniela Luethy, Georgia Skelton iD, Jeaneen Kulp, Darko Stefanovski, Andrew W van Eps

Journal of the American Veterinary Medical Association · 01.09.2026 · 264 (9) · 1200-1209

DOI: 10.2460/javma.26.02.0098 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of the American Veterinary Medical Association, erschienen am 01.09.2026. Verfasst von Caitrin R Lowndes und 5 weiteren Autor:innen. Hauptthemen laut MEDLINE: Glycosides, Horse Diseases, Hyperinsulinism, Insulin. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

To evaluate bexagliflozin for insulin control in horses with naturally occurring insulin dysregulation.

Methods

In a randomized, placebo-controlled crossover study, 10 client-owned Arabian horses with hyperinsulinemia (> 30 μIU/mL) were treated with bexagliflozin (0.03 mg/kg, PO, q 24 h; BEXA03) or placebo control for a 10-day treatment period, crossing over after a 4-day washout. After a further 12-day washout, 8 of the horses were treated with bexagliflozin (0.06 mg/kg, PO, q 24 h; BEXA06) for an additional 7-day treatment period. Oral sugar tests were performed at the beginning of each treatment period (untreated control) and on the final day of each treatment course. Insulin, glucose, triglycerides, and adipokines were compared with mixed-effects linear regression.

Results

Mean resting, maximal (C max ), and area under the curve (AUC) insulin were lower after BEXA06 (resting, 17.6 μIU/mL [95% CI, 5.3 to 29.9 μIU/mL]; C max , 48.4 μIU/mL [95% CI, 24.0 to 72.8 μIU/mL]; AUC, 4,084.0 μIU/mL*min [95% CI, 1,944.4 to 6,223.5 μIU/mL*min]) compared to placebo control (resting, 53.9 μIU/mL [95% CI, 35.0 to 72.7 μIU/mL]; C max , 90.9 μIU/mL [95% CI, 65.0 to 116.9 μIU/mL]; AUC, 9,146.3 μIU/mL*min [95% CI, 6,428.9 to 11,863.7 μIU/mL*min]), but not after BEXA03. Mild hypertriglyceridemia was observed in some horses following treatment with BEXA06 (n = 5), but mean resting triglyceride concentrations were not significantly higher for BEXA06 (49 mg/dL; 95% CI, 30 to 67 mg/dL) compared to the untreated control (32 mg/dL; 95% CI, 26 to 38 mg/dL).

Conclusions

Bexagliflozin (0.06 mg/kg, PO, q 24 h) controlled insulin with minimal impact on serum triglycerides in Arabian horses with naturally occurring insulin dysregulation. Clinical Relevance Treatment with bexagliflozin was effective for the short-term management of naturally occurring insulin dysregulation in horses.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

GlycosidesHorse DiseasesHyperinsulinismInsulinAnimalsFemaleMaleBlood GlucoseCross-Over StudiesHorses

Stichwörter der Autor:innen

SGLT-2ibexagliflozinequine metabolic syndromeinsulin dysregulationtriglycerides

Substanzen

Blood GlucoseGlycosidesInsulin

Autor:innen und Institutionen

ORCID-Profile: Georgia Skelton

Zitieren

APA

Lowndes, C. R., Luethy, D., Skelton, G., Kulp, J., Stefanovski, D., & van Eps, A. W. (2026). Bexagliflozin controls hyperinsulinemia in horses with naturally occurring insulin dysregulation: a placebo-controlled crossover trial. Journal of the American Veterinary Medical Association, 264(9), 1200-1209. https://doi.org/10.2460/javma.26.02.0098

Vancouver

Lowndes CR, Luethy D, Skelton G, Kulp J, Stefanovski D, van Eps AW. Bexagliflozin controls hyperinsulinemia in horses with naturally occurring insulin dysregulation: a placebo-controlled crossover trial. Journal of the American Veterinary Medical Association. 2026;264(9):1200-1209. doi:10.2460/javma.26.02.0098

BibTeX
@article{Lowndes2026,
  author = {Lowndes, Caitrin R and Luethy, Daniela and Skelton, Georgia and Kulp, Jeaneen and Stefanovski, Darko and van Eps, Andrew W},
  title = {Bexagliflozin controls hyperinsulinemia in horses with naturally occurring insulin dysregulation: a placebo-controlled crossover trial},
  journal = {Journal of the American Veterinary Medical Association},
  year = {2026},
  volume = {264},
  number = {9},
  pages = {1200--1209},
  doi = {10.2460/javma.26.02.0098}
}
Kostenlos starten →